At the Innovative Strategies for Patient Centered Clinical Research Conference, July 11-12, 2018 in Boston, MA will bring together the foremost leaders in Clinical Innovation, Clin
Johnson & Johnson is planning a phase 3 programme for Rybrevant in colorectal cancer as a follow-up to its first indication in non-small cell lung cancer (NSCLC), after reporting encour
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo